PubMed Health⌕ Search

PubMed · 14641335

Mohs tissue mapping and processing: a survey study.

Abstract

BACKGROUND: Mohs micrographic surgery (MMS) is the most reliable, conservative, and tissue-sparing approach to the management of cutaneous malignancies. The concept of MMS is simple, but its technique, which involves a series of suboperations, is complex. OBJECTIVE: To define which techniques of Mohs tissue mapping and processing are presently employed by members of the American College of Mohs Micrographic Surgery and Cutaneous Oncology. METHODS: Five hundred eighty surveys of eight questions regarding different techniques used in Mohs tissue mapping and processing were mailed out to Mohs micrographic surgeons registered with the American College of Mohs Micrographic Surgery and Cutaneous Oncology. A total of 310 responses (53%) were collected between October and December 2002. The results were tabulated and analyzed. RESULTS: Most Mohs micrographic surgeons personally prepare the map of the tissue in relationship to the patient (66.5%). A hand-drawn picture with standard orientations is most frequently used to map and orient a tissue specimen (69.4%). Histotechnicians usually prepare the tissue specimen for cryostat processing (63.5%). A heat extractor and/or tissue cuts or "slits" are the preferred methods used to flatten tissue by 52.9% of respondents. Hematoxylin and eosin is the stain that is most commonly used (82.6%). Approximately 50% of Mohs micrographic surgeons cut the excised specimen from the first stage into two separate pieces. Each tissue piece is then commonly processed into three to six representative serial sections per glass slide (68.1%). These sections are most commonly cut at 5 to 6 microm (53.9%) and less frequently at 4 microm (21.9%). CONCLUSION: There is variability in mapping and processing techniques employed Mohs micrographic surgeons and their histotechnicians. As long as the integrity of each step of Mohs tissue mapping and processing is preserved, the high cure rate of the technique should be maintained.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sirunya Silapunt, S Ray Peterson, Joseph Alcalay, Leonard H Goldberg. 2003. Mohs tissue mapping and processing: a survey study.. https://pubmed.ncbi.nlm.nih.gov/14641335/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Development of an indicator system for evaluating the quality of health care services].

Indicator system development for evaluating the quality of health services. The National Health Insurance Fund of Hungary introduces indicators for evaluating the quality of health services. The new system starts by the end of 2003 on the Internet and it will be updated and improved on a regular base. The quality indicators provide possibility to compare the health services and follow up the changes. The Hungarian indicators came from those indicators, which are described, tested and used in the international literature and practice. The data derive from the routinely collected financial data of the National Health Insurance Fund. The conclusions drawn form the results will be arranged and interpreted according to the types of indicators. Those providers whose have out of the ordinary values should fill in a standardized questionnaire--which was developed with the representatives of the certain profession--for explaining the results and define quality improvement plan. The aim of the programme is to increase transparency of health services, to enhance quality improvement and to support the certification and accreditation programmes.

Health Care Surveys↗

A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.

Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and patients' use of opportunities for HCV antibody testing in a large sample of methadone and drug-free treatment programs (N=256) in the US, and reports programs' recent changes and future plans concerning it. Results indicate that almost all methadone and about two-thirds of drug-free programs in the sample provided HCV antibody screening to at least some patients in 2001. While about two-thirds of the methadone and close to one-third of the drug-free programs offered this service to all patients, these programs report that only about 3/5 of their patients actually provided specimens for testing for HCV antibodies. Some drug treatment programs were planning to increase the availability and accessibility of HCV antibody screening, but others were planning to cut back on these services, primarily due to limited resources. These results can inform policymakers who advocate for increased HCV antibody screening in drug treatment programs about the current level and future plans for implementing these services, illuminating where resources and motivational efforts need to be targeted.

Health Care Surveys↗